Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. FDA Drug Information Updates

The FDA's Adverse Event Reporting System (FAERS) Public Dashboard

ReachMD Healthcare Image
Restart
Resume
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Comments
  • Overview

    Many listeners may be familiar with the FDA's Adverse Event Reporting System or FAERS.  Data in FAERS supports the FDA's post-marketing safety surveillance program for drug products and therapeutic biologic products.  Recently, CDER's Office of Surveillance and Epidemiology created and released a tool that makes FAERS data easier to query and retrieve.  This new interactive dashboard is designed to expand access of FAERS data to the general public.

    Dr. Janet Woodcock, Director of the FDA Center for Drug Evaluation and Research, discusses the advantages of the tool as well as its limitations.

Recommended
Details
Comments
  • Overview

    Many listeners may be familiar with the FDA's Adverse Event Reporting System or FAERS.  Data in FAERS supports the FDA's post-marketing safety surveillance program for drug products and therapeutic biologic products.  Recently, CDER's Office of Surveillance and Epidemiology created and released a tool that makes FAERS data easier to query and retrieve.  This new interactive dashboard is designed to expand access of FAERS data to the general public.

    Dr. Janet Woodcock, Director of the FDA Center for Drug Evaluation and Research, discusses the advantages of the tool as well as its limitations.

Schedule12 Dec 2024